PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
01-Aug-2024 As blood stock shortage crisis continues, less than half of Brits know their blood type, says expert London Medical Laboratory
01-Aug-2024 Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies Novo Holdings
01-Aug-2024 INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA ANGLE plc
01-Aug-2024 GenesisCare UK Strengthens Board with Appointment of Three Non-Executive Directors GenesisCare UK
31-Jul-2024 Polish Ministry of Health approves reimbursement of POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome Kyowa Kirin International (KKI)
31-Jul-2024 CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction CellProthera
30-Jul-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion
30-Jul-2024 Creative Proteomics Revolutionizes Metabolomics Research with Launch of Nucleotide Sugars Analysis Service Creative Proteomics
30-Jul-2024 Creative Proteomics Redefines Excellence in Exosome Proteomics Services Creative Proteomics
30-Jul-2024 Alfa Chemistry: A Source of Hundreds of Surfactants as Cleansing Agents for Household Scenarios Alfa Chemistry
30-Jul-2024 Alfa Chemistry Releases Dozens of Polyquaternium Chemicals as Cosmetic Ingredients for the Personal Care Industry Alfa Chemistry
29-Jul-2024 Amprion Unveils Next-Generation SAAmplifyâ„¢ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024 Amprion
29-Jul-2024 Creative Enzymes Redefines Sustainability in Enzyme Innovation with Yeast-Fermented Vegan Collagen Creative Enzymes
25-Jul-2024 ACG Packaging Materials wins prestigious Kepner-Tregoe (KT) Excellence Award ACG
25-Jul-2024 DiogenX strengthens executive committee with Hélène Sicard joining as Chief Development Officer Andrew Lloyd Associates
24-Jul-2024 ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors ImmunOs Therapeutics
24-Jul-2024 SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) SpyBiotech
24-Jul-2024 Alfa Chemistry Extends Product Line with Comprehensive PTFE , PCTFE , ETFE, and Fluoropolymer Coatings Offerings Alfa Chemistry
23-Jul-2024 Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial PureTech Health
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell